Effect of angiotensin II and endothelin-I receptor blockade on the haemodynamic and hormonal changes after acute blood loss and after retransfusion in conscious dogs

Acta Physiologica Scandinavica

Volumn 180, Issue 4, 2004, Pages 319-328

  Francis, R C E ^a   Hohne C ^a   Kaczmarczyk, G ^a   Boemke, W ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

ABT 627; Cardiac output; Circulation; Haemorrhage; Losartan; Renal excretion; Shock

Indexed keywords

ADRENALIN; ANGIOTENSIN; ANGIOTENSIN RECEPTOR; ANGIOTENSIN RECEPTOR ANTAGONIST; ATRASENTAN; ENDOTHELIN 1; ENDOTHELIN 1 RECEPTOR; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN RECEPTOR; HORMONE; LOSARTAN; NORADRENALIN; UNCLASSIFIED DRUG; VASOPRESSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLEEDING; BLOOD TRANSFUSION; CONSCIOUSNESS; CONTROLLED STUDY; DOG; FEMALE; GLOMERULUS FILTRATION RATE; HEART OUTPUT; HEMOCONCENTRATION; HEMODYNAMICS; HORMONE ACTION; HYPOTENSION; KIDNEY; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BLOCKING; RECORDING; TIME; URINE VOLUME;

ANGIOTENSIN II; ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD TRANSFUSION; CARDIAC OUTPUT; DOGS; ENDOTHELIN-1; EPINEPHRINE; FEMALE; GLOMERULAR FILTRATION RATE; HEMODYNAMIC PROCESSES; HEMORRHAGE; LOSARTAN; NOREPINEPHRINE; PYRROLIDINES; RECEPTOR, ENDOTHELIN A; STROKE VOLUME; URINE; VASCULAR RESISTANCE; VASOPRESSINS;

EID: 1942438091     PISSN: 00016772     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-201X.2004.01265.x     Document Type: Article

References (40)

1. Ardaillou, R. 1999. Angiotensin II Receptors. J Am Soc Nephrol 10, S30-S39.
2. Balakrishnan, S.M., Wang, H.D., Gopalakrishnan, V., Wilson, T.W. & McNeill, J.R. 1996. Effect of an endothelin antagonist on hemodynamic responses to angiotensin II. Hypertension 28, 806-809.
3. Boemke, W., Hocher, B., Schleyer, N., Krebs, M.O. & Kaczmarczyk, G. 2001. Hemodynamic, renal, and endocrine responses to acute ET-A blockade at different ANG II plasma levels. Am J Physiol 280, R1322-R1331.
4. Burnier, M. & Brunner, H.R. 2000. Angiontensin II receptor antagonists. Lancet 355, 637-645.
5. Committee on Care and Use of Laboratory Animals 1996. Guide for the Care and Use of Laboratory Animals. Institute of Laboratory Animal Resource, National Research Council, DHHS. National Academy of Sciences, Washington.
6. Davis, J.O. & Freeman, R.H. 1976. Mechanisms regulating renin release. Phys Rev 56, 1-56.
7. Donckier, J., Stoleru, L., Hayashida, W. et al. 1995. Role of endogenous endothelin-1 in experimental renal hypertension in dogs. Circulation 92, 106-113.
8. Hall, J.E. 1986. Regulation of glomerular filtration rate and sodium excretion by angiotensin II. Federation Proc 45, 1431-1437.
9. Haynes, W.G. & Webb, D.J. 1993. The endothelin family of peptides: local hormones with diverse roles in health and disease. Clin Sci 84, 485-500.
10. Haynes, W.G., Strachan, F.E. & Webb, D.J. 1995. Endothelin ET-A and ET-B receptors cause vasoconstriction of human resistance and capacitance vessels in vivo. Circulation 92, 357-363.
11. Haynes, W.G., Ferro, C.J., O'Kane, K.P.J., Somerville, D., Lomax, C.C. & Webb, D.J. 1996. Systemic endothelin receptor blockade decreases peripheral vascular resistance and blood pressure in humans. Circulation 93, 1860-1870.
12. Hoekstra, J.W., Dronen, S.C. & Hedges, J.R. 1988. Effects of splenectomy on hemodynamic performance in fixed volume canine hemorrhagic shock. Circ Shock 25, 95-101.
13. Höhne, C., Francis, R.C.E., Kaczmarczyk, G. & Boemke, W. 2002. Haemodynamic and hormonal changes during haemorrhage in conscious dogs treated with an endothelin-A receptor antagonist. Clin Sci 103(Suppl. 48), 336S-339S.
14. Hosokawa, A., Nagayama, T., Yoshida, M. et al. 2000. Facilitation and inhibition by endothelin-1 of adrenal catecholamine secretion in anesthetized dogs. Eur J Pharmacol 397, 55-61.
15. Jansen, J.R.C., Schreuder, J.J., Settels, J.J., Kloek, J.J. & Versprille, A. 1990. An adequate strategy for the thermodilution technique in patients during mechanical ventilation. Intensive Care Med 16, 422-425.
16. Kimura, T. & Suzuki, Y. 1992. Facilitatory role of the renin-angiotensin system in controlling adrenal catecholamine release in hemorrhaged dogs. J Cardiovasc Pharmacol 19, 975-981.
17. Kon, V. & Badr, K.F. 1991. Biological actions and pathophysiologic significance of endothelin in the kidney. Kidney Int 40, 1-12.
18. Krebs, M.O., Kröhn, T., Boemke, W., Mohnhaupt, R. & Kaczmarczyk, G. 1999. Renal and hemodynamic effects of losartan in conscious dogs during controlled mechanical ventilation. Am J Physiol 276, F425-F432.
19. Löffler, B.-M., Breu, V. & Clozel, M. 1993. Effect of different endothelin receptor antagonists and of the novel non-peptide antagonist Ro46-2005 on endothelin levels in rat plasma. FEBS Lett 333, 108-110.
20. Masaki, T. 1993. Endothelins: homeostatic and compensatory actions in the circulatory and endocrine system. Endocr Rev 14, 256-268.
21. 1 receptor blockade in the brain on the maintenance of blood pressure during haemorrhage in sheep. Acta Physiol Scand 161, 495-502.
22. Moreau, P., d'Uscio, L.V., Shaw, S., Takase, H., Barton, M. & Lüscher, T.F. 1997. Angiotensin II increases tissue endothelin and induces vascular hypertrophy. Circulation 96, 1593-1597.
23. Nagayama, T., Kuwakubo, F., Matsumoto, T. et al. 2000. Role of endogenous endothelins in catecholamine secretion in the rat adrenal gland. Eur J Pharmacol 406, 69-74.
24. B-receptor-mediated inhibition of noradrenaline release from isolated rat stomach. J Pharmacol Sci 91, 34-40.
25. Oliver, J.R., Korner, P.I., Woods, R.L. & Zhu, J.L. 1990. Reflex release of vasopressin and renin in hemorrhage is enhanced by autonomic blockade. Am J Physiol 258, H221-H228.
26. Opgenorth, T.J., Wessale, J.L., Dixon, D.E. et al. 2000. Effects of endothelin receptor antagonists on the plasma immunoreactive endothelin-1 level. J Cardiovasc Pharmacol 36(Suppl. 1), 292-296.
27. B-receptors in haemodynamic compensation following haemorrhage in anaesthetized rats. Br J Pharmacol 135, 876-882.
28. Ryckwaert, F., Colson, P., André, E., Perrigault, P.-F., Guillon, G. & Barberis, C. 2002. Haemodynamic effects of an angiotensin-converting enzyme inhibitor and angiotensin receptor antagonist during hypovolemia in the anaesthetized pig. Br J Anaesth 89, 599-604.
29. Schaffer, J.P. 1986. Modified sequentially rejective multiple test procedures. J Am Statist Assoc 81, 826-831.
30. Secher, N.H. & Bie, P. 1985. Bradycardia during reversible haemorrhagic shock - a forgotten observation? Clin Physiol 5, 315-323.
31. Shen, Y.-T., Knight, D.R., Thomas, J.X. Jr., Cowley, A.W. Jr. & Vatner, S.F. 1988. Cardiac receptors are not the major regulators of vasopressin release during hemorrhage in conscious dogs. Circulation 78(Suppl. II), 522.
32. Siragy, H.M. 2002. Angiotensin receptor blockers: how important is selectivity? Am J Hypertens 15, 1006-1014.
33. A receptor blockade in patients with congestive heart failure. J Am Coll Cardiol 35, 1745-1752.
34. Suzuki, Y., Matsumara, Y., Umekawa, T., Hayashi, K., Takaoka, M. & Morimoto, S. 1992. Effects of endothelin-1 on antidiuresis and norepinephrine overflow induced by stimulation of renal nerves in anesthetized dogs. J Cardiovasc Pharmacol 19, 905-910.
35. Teerlink, J.R., Carteaux, J.-P., Sprecher, U., Löffler, B.-M., Clozel, M. & Clozel, J.-P. 1995. Role of endogenous endothelin in normal hemodynamic status of anesthetized dogs. Am J Physiol 268, H432-H440.
36. Tournadre, J.P., Chassard, D. & Muchada, R. 1997. Overestimation of cardiac output measured by thermodilution. Br J Anaesth 79, 514-516.
37. Vatner, S. 1974. Effects of hemorrhage on regional blood flow distribution in dogs and primates. J Clin Invest 54, 225-235.
38. Verhaar, M.C., Grahn, A.Y., van Weerdt, A.W.M. et al. 2000. Pharmacokinetics and pharmacodynamic effects of ABT-627, an oral ET-A selective endothelin antagonist, in humans. J Clin Pharmacol 49, 562-573.
39. Webb, D.J. & Strachan, F.E. 1998. Clinical experience with endothelin antagonists. Am J Hypertens 11, 71S-79S.
40. Zimmermann, R.S., Maymind, M. & Barbee, R.W. 1994. Endothelin blockade lowers total peripheral resistance in hemorrhagic shock recovery. Hypertension 23, 205-210.